This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Regeneron Pharmaceuticals, Inc.
Drug Names(s): IL-4/IL-13 Trap, Interleukin-4/Interleukin-13 Trap
Description: The IL-4/13 Trap, a novel protein biologic agent, functions by binding with high affinity to either IL-4 or IL-13 to form an inactive complex. The IL-4/13 Trap contains only human sequences.
IL-4/13 Trap News
Pink Sheet Weekly Trademark Review Oct. 28, 2014
Additional information available to subscribers only: